Tara Mirzadegan

1.9k total citations
25 papers, 1.5k citations indexed

About

Tara Mirzadegan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Tara Mirzadegan has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Tara Mirzadegan's work include Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (4 papers) and Photoreceptor and optogenetics research (3 papers). Tara Mirzadegan is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (4 papers) and Photoreceptor and optogenetics research (3 papers). Tara Mirzadegan collaborates with scholars based in United States, Switzerland and France. Tara Mirzadegan's co-authors include Krzysztof Palczewski, Gil Benkö, Sławomir Filipek, Klaus Klumpp, Kurt Jarnagin, Mary A. Mulkins, Sunil Bhakta, Marianna Dioszegi, Surya Sankuratri and Jun Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Tara Mirzadegan

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Mirzadegan United States 16 933 301 295 255 208 25 1.5k
Terence G. Porter United States 13 733 0.8× 167 0.6× 229 0.8× 605 2.4× 201 1.0× 16 1.7k
Soumya S. Ray United States 27 1.4k 1.5× 73 0.2× 169 0.6× 182 0.7× 236 1.1× 41 2.2k
Kvido Střı́šovský Czechia 24 1.1k 1.2× 118 0.4× 173 0.6× 89 0.3× 83 0.4× 46 1.7k
Heidi A. Zürcher-Neely United States 18 1.0k 1.1× 127 0.4× 209 0.7× 140 0.5× 118 0.6× 22 1.6k
Jeffrey S. Culp United States 13 676 0.7× 82 0.3× 98 0.3× 117 0.5× 215 1.0× 15 1.3k
J. Fraser Glickman United States 22 1.5k 1.6× 159 0.5× 303 1.0× 513 2.0× 29 0.1× 47 2.2k
Alex Smolyar United States 16 1.4k 1.4× 202 0.7× 179 0.6× 1.0k 4.0× 75 0.4× 27 2.4k
Scott L. Harbeson United States 17 703 0.8× 303 1.0× 228 0.8× 52 0.2× 61 0.3× 28 1.7k
Irma Lemmens Belgium 19 1.3k 1.4× 84 0.3× 441 1.5× 159 0.6× 52 0.3× 42 2.1k
Maulik Patel United States 25 981 1.1× 181 0.6× 218 0.7× 195 0.8× 25 0.1× 73 1.7k

Countries citing papers authored by Tara Mirzadegan

Since Specialization
Citations

This map shows the geographic impact of Tara Mirzadegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Mirzadegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Mirzadegan more than expected).

Fields of papers citing papers by Tara Mirzadegan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Mirzadegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Mirzadegan. The network helps show where Tara Mirzadegan may publish in the future.

Co-authorship network of co-authors of Tara Mirzadegan

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Mirzadegan. A scholar is included among the top collaborators of Tara Mirzadegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Mirzadegan. Tara Mirzadegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
parks, conor, Zied Gaieb, Michael Chiu, et al.. (2020). D3R grand challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies. Journal of Computer-Aided Molecular Design. 34(2). 99–119. 85 indexed citations
2.
Gaieb, Zied, conor parks, Michael Chiu, et al.. (2019). D3R Grand Challenge 3: blind prediction of protein–ligand poses and affinity rankings. Journal of Computer-Aided Molecular Design. 33(1). 1–18. 97 indexed citations
3.
Vlijmen, Herman van, Renée L. DesJarlais, & Tara Mirzadegan. (2016). Computational chemistry at Janssen. Journal of Computer-Aided Molecular Design. 31(3). 267–273. 14 indexed citations
4.
Blevitt, Jonathan M., Michael D. Hack, Krystal Herman, et al.. (2016). A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors. Journal of Biological Chemistry. 291(24). 12724–12731. 12 indexed citations
5.
Minassian, Natali A., Alan C. Gibbs, Amy Y. Shih, et al.. (2013). Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (μ-TRTX-Hh2a). Journal of Biological Chemistry. 288(31). 22707–22720. 61 indexed citations
6.
7.
Repke, David B., Keith A. M. Walker, Renée S. Martin, et al.. (2010). Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism. Bioorganic & Medicinal Chemistry Letters. 20(11). 3436–3440. 33 indexed citations
8.
Kondru, Rama K., Jun Zhang, Changhua Ji, et al.. (2007). Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists. Molecular Pharmacology. 73(3). 789–800. 153 indexed citations
9.
Klumpp, Klaus & Tara Mirzadegan. (2006). Recent Progress in the Design of Small Molecule Inhibitors of HIV RNase H. Current Pharmaceutical Design. 12(15). 1909–1922. 64 indexed citations
10.
Hang, Julie Q., Yu Li, Yanli Yang, et al.. (2006). Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs). Biochemical and Biophysical Research Communications. 352(2). 341–350. 42 indexed citations
11.
Campbell, Jeffrey A., Chris A. Broka, Michelle F. Browner, et al.. (2004). Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(18). 4741–4745. 52 indexed citations
12.
Elworthy, Todd R., Frances Chu, Jason Harris, et al.. (2004). Lactams as EP4Prostanoid Receptor Agonists. 3. Discovery ofN-Ethylbenzoic Acid 2-Pyrrolidinones as Subtype Selective Agents. Journal of Medicinal Chemistry. 47(25). 6124–6127. 28 indexed citations
13.
Mirzadegan, Tara, et al.. (2003). Sequence Analyses of G-Protein-Coupled Receptors:  Similarities to Rhodopsin. Biochemistry. 42(14). 4310–4310. 11 indexed citations
14.
Tecle, Haile, Roy D. Schwarz, Stephen D. Barrett, et al.. (2000). CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology. Pharmaceutica Acta Helvetiae. 74(2-3). 141–148. 11 indexed citations
15.
Mirzadegan, Tara, Frank Diehl, Sunil Bhakta, et al.. (2000). Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists. Journal of Biological Chemistry. 275(33). 25562–25571. 205 indexed citations
16.
Hemmerich, Stefan, Chad D. Paavola, A. Joseph Bloom, et al.. (1999). Identification of Residues in the Monocyte Chemotactic Protein-1 That Contact the MCP-1 Receptor, CCR2. Biochemistry. 38(40). 13013–13025. 130 indexed citations
17.
McGrath, Mary E., Tara Mirzadegan, & Brian F. Schmidt. (1997). Crystal Structure of Phenylmethanesulfonyl Fluoride-Treated Human Chymase at 1.9 Å. Biochemistry. 36(47). 14318–14324. 42 indexed citations
18.
Schwarz, Roy D., Juan C. Jaén, Tara Mirzadegan, et al.. (1995). Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists. Life Sciences. 56(11-12). 923–929. 13 indexed citations
19.
Tecle, Haile, Robert E. Davis, Tara Mirzadegan, et al.. (1995). (±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists. Bioorganic & Medicinal Chemistry Letters. 5(6). 637–642. 4 indexed citations
20.
Tecle, Haile, Tara Mirzadegan, Walter H. Moos, et al.. (1993). Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists. Life Sciences. 52(5-6). 505–511. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terence G. Porter Breakdown of academic impact, for papers by Soumya S. Ray Breakdown of academic impact, for papers by Kvido Střı́šovský Breakdown of academic impact, for papers by Heidi A. Zürcher-Neely Breakdown of academic impact, for papers by Jeffrey S. Culp Breakdown of academic impact, for papers by J. Fraser Glickman Breakdown of academic impact, for papers by Alex Smolyar Breakdown of academic impact, for papers by Scott L. Harbeson Breakdown of academic impact, for papers by Irma Lemmens Breakdown of academic impact, for papers by Maulik Patel
Rankless by CCL
2026